These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25574917)

  • 21. Molecular mechanism of rifampicin and isoniazid resistance in Mycobacterium tuberculosis from Bangladesh.
    Rahim Z; Nakajima C; Raqib R; Zaman K; Endtz HP; van der Zanden AG; Suzuki Y
    Tuberculosis (Edinb); 2012 Nov; 92(6):529-34. PubMed ID: 22863574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
    Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
    Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotype MTBDR plus assay for molecular detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
    Sharma S; Madan M; Agrawal C; Asthana AK
    Indian J Pathol Microbiol; 2014; 57(3):423-6. PubMed ID: 25118735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
    Jiao WW; Mokrousov I; Sun GZ; Li M; Liu JW; Narvskaya O; Shen AD
    Chin Med J (Engl); 2007 May; 120(9):814-9. PubMed ID: 17531124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic performance of the Xpert MTB/RIF assay for tuberculous lymphadenitis on fine needle aspirates from Ethiopia.
    Biadglegne F; Mulu A; Rodloff AC; Sack U
    Tuberculosis (Edinb); 2014 Sep; 94(5):502-5. PubMed ID: 24931451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
    Valvatne H; Syre H; Kross M; Stavrum R; Ti T; Phyu S; Grewal HM
    J Antimicrob Chemother; 2009 Oct; 64(4):694-701. PubMed ID: 19710078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotypic characterization of 'inferred' rifampin mutations in GenoType MTBDRplus assay and its association with phenotypic susceptibility testing of Mycobacterium tuberculosis.
    Singhal R; Anthwal D; Kumar G; Sah G; Salfinger M; Choudhury S; Arora J; Bhalla M; Myneedu VP; Sarin R; Haldar S
    Diagn Microbiol Infect Dis; 2020 Apr; 96(4):114995. PubMed ID: 32037037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The occurrence of rare rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait.
    Ahmad S; Mokaddas E
    Int J Antimicrob Agents; 2005 Sep; 26(3):205-12. PubMed ID: 16099622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Xpert(®) MTB/RIF assay: diagnosis and treatment outcomes in rifampicin-resistant tuberculosis.
    Kim YW; Seong MW; Kim TS; Yoo CG; Kim YW; Han SK; Yim JJ
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1216-21. PubMed ID: 26459536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?
    Trébucq A; Enarson DA; Chiang CY; Van Deun A; Harries AD; Boillot F; Detjen A; Fujiwara PI; Graham SM; Monedero I; Rusen ID; Rieder HL
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1567-72. PubMed ID: 22005110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations.
    Rigouts L; Gumusboga M; de Rijk WB; Nduwamahoro E; Uwizeye C; de Jong B; Van Deun A
    J Clin Microbiol; 2013 Aug; 51(8):2641-5. PubMed ID: 23761146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid detection of mutations in rpoB gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay.
    Sharma M; Sethi S; Mishra B; Sengupta C; Sharma SK
    Indian J Med Res; 2003 Feb; 117():76-80. PubMed ID: 12931842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rifampicin resistance patterns and dynamics of tuberculosis and drug-resistant tuberculosis in Enugu, South Eastern Nigeria.
    Ugwu KO; Onah IS; Mbah GC; Ezeonu IM
    J Infect Dev Ctries; 2020 Sep; 14(9):1011-1018. PubMed ID: 33031090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.
    Höfling CC; Pavan EM; Giampaglia CM; Ferrazoli L; Aily DC; de Albuquerque DM; Ramos MC
    Int J Tuberc Lung Dis; 2005 Jan; 9(1):87-93. PubMed ID: 15675556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Disputed Mutations in the
    Miotto P; Cabibbe AM; Borroni E; Degano M; Cirillo DM
    J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29540456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The GenoType® MTBDRplus assay for detection of drug resistance in Mycobacterium tuberculosis in Sweden.
    Chryssanthou E; Angeby K
    APMIS; 2012 May; 120(5):405-9. PubMed ID: 22515295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic screening for drug-resistant tuberculosis with Xpert(®) MTB/RIF in a referral hospital in Cambodia.
    Lorent N; Kong C; Kim T; Sam S; Thai S; Colebunders R; Rigouts L; Lynen L
    Int J Tuberc Lung Dis; 2015 Dec; 19(12):1528-35. PubMed ID: 26614197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular analysis of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis isolates by multiple allele specific polymerase chain reaction in Puducherry, South India.
    Thirumurugan R; Kathirvel M; Vallayyachari K; Surendar K; Samrot AV; Muthaiah M
    J Infect Public Health; 2015; 8(6):619-25. PubMed ID: 26117709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypically occult multidrug-resistant Mycobacterium tuberculosis: dilemmas in diagnosis and treatment.
    Ho J; Jelfs P; Sintchencko V
    J Antimicrob Chemother; 2013 Dec; 68(12):2915-20. PubMed ID: 23838950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.